These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11791080)

  • 1. Improving continuation rates for hormone replacement therapy.
    Gambrell RD
    Menopause; 2002; 9(1):3-5. PubMed ID: 11791080
    [No Abstract]   [Full Text] [Related]  

  • 2. Is progestogen supplementation of ERT really necessary?
    Naftolin F; Silver D
    Menopause; 2002; 9(1):1-2. PubMed ID: 11791079
    [No Abstract]   [Full Text] [Related]  

  • 3. [Estrogens following menopause. Methods of hormone replacement].
    Robyn C
    Rev Med Brux; 1995; 16(4):291-4. PubMed ID: 7481245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The uterus and the menopause.
    Rees MC
    Baillieres Clin Obstet Gynaecol; 1996 Sep; 10(3):419-32. PubMed ID: 8931903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen-progestin replacement therapy and endometrial cancer.
    Pike MC; Peters RK; Cozen W; Probst-Hensch NM; Felix JC; Wan PC; Mack TM
    J Natl Cancer Inst; 1997 Aug; 89(15):1110-6. PubMed ID: 9262248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gynecologic complications of cyclic estrogen progestin therapy.
    Ettinger B; Selby JV; Citron JT; Ettinger VM; Zhang D
    Maturitas; 1993 Nov; 17(3):197-204. PubMed ID: 8133794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On menstrual bleeding with hormone replacement therapy.
    Rees M
    Lancet; 1994 Jan; 343(8892):250. PubMed ID: 7905092
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
    Kuller LH
    J Natl Cancer Inst; 2000 Jul; 92(13):1100-1. PubMed ID: 10880556
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: estrogen-progestin replacement therapy and endometrial cancer.
    McKnight B; Voigt LF; Beresford SA; Weiss NS
    J Natl Cancer Inst; 1998 Jan; 90(2):164-6. PubMed ID: 9450582
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hormone replacement therapy and endometrial cancer].
    Concin H; Sommerlechner M
    Gynakol Geburtshilfliche Rundsch; 1998; 38(2):93-5. PubMed ID: 9815525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of endometrial spotting or bleeding during continuous-combined estrogen-progestin therapy in postmenopausal women with and without hypertension.
    Sriprasert I; Beydoun H; Barnabei V; Nassir R; LaCroix AZ; Archer DF
    Menopause; 2015 Oct; 22(10):1067-75. PubMed ID: 25756697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progestogens in postmenopausal hormone therapy and the risk of breast cancer.
    Lambrinoudaki I
    Maturitas; 2014 Apr; 77(4):311-7. PubMed ID: 24485796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrauterine application of progestins in hormone replacement therapy: a review.
    Riphagen FE
    Climacteric; 2000 Sep; 3(3):199-211. PubMed ID: 11910622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing the problems of the progestogen.
    Sturdee DW; MacLennan AH
    Climacteric; 2006 Aug; 9(4):241-3. PubMed ID: 16857653
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
    JAMA; 1996 Feb; 275(5):370-5. PubMed ID: 8569016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endometrial adenocarcinoma after prolonged tibolone therapy.
    Nassar AH; Khalil AM; Seoud MA; Usta IM
    Int J Gynaecol Obstet; 2005 Jul; 90(1):78-9. PubMed ID: 15913616
    [No Abstract]   [Full Text] [Related]  

  • 17. Is combined estrogen/progestogen hormone therapy worth the risk?
    Sturdee DW; MacLennan AH
    Climacteric; 2003 Sep; 6(3):177-9. PubMed ID: 14567764
    [No Abstract]   [Full Text] [Related]  

  • 18. Postmenopausal hormone replacement therapy: does the progestin make a difference?
    Fylstra DL
    J S C Med Assoc; 2002 Feb; 98(1):12-9. PubMed ID: 11859600
    [No Abstract]   [Full Text] [Related]  

  • 19. Postmenopausal uterine bleeding profiles with two forms of continuous combined hormone replacement therapy.
    Johnson JV; Davidson M; Archer D; Bachmann G
    Menopause; 2002; 9(1):16-22. PubMed ID: 11791082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometrial cancer risk in estrogen users after switching to estrogen-progestin therapy.
    Chubak J; Doherty JA; Cushing-Haugen KL; Voigt LF; Saltzman BS; Hill DA; Beresford SA; Weiss NS
    Cancer Causes Control; 2007 Nov; 18(9):1001-7. PubMed ID: 17653829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.